Taubman Institute welcomes new gift officer
The Taubman Institute has a new ally in its quest to support the lifesaving work of U-M’s most promising clinician-scientists.
Maria Muller has been assigned by the university’s office of medical development to serve as the Taubman Institute’s lead development officer. She’ll be working with benefactors and prospective supporters to create giving opportunities that fulfill the aims of donors while underwriting important institute efforts such as the Emerging Scholars Program.
Muller brings a robust background in higher education fundraising. A native of Ohio, she began her development career at Harvard University, shepherding major gifts for Harvard’s business and public health schools, the Kennedy School of Government and the fundraising activities of the university president’s office among others.
Returning to her Midwestern roots, Muller served as a major gifts officer for the U-M College of Engineering, working with alumni and individual supporters, facilitating corporate support of scholarships, internships and other initiatives. But the special rewards and challenges of engaging support for medical research really appeal to her, she says.
“People want to be actively engaged, and at the Taubman Institute we have very special opportunities for that,” Muller said. “There is a way to help our donors be part of the dynamic conversation about healthcare, and to experience the transformative power of individual philanthropy -- right here where we are aggressively working to save people. For a development officer, that’s rarefied air.”
“We are delighted, and very fortunate, to have Maria as our colleague and champion,” said Taubman Institute Director Eva L. Feldman, M.D., Ph.D. “The scholars and I, along with Mr. Taubman, are very impressed by her acumen, energy and enthusiasm. I know our generous supporters will greatly enjoy working with her.”
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.